The stock of Exponent, Inc. (NASDAQ:EXPO) hit a new 52-week high and has $68.29 target or 9.00% above today’s $62.65 share price. The 6 months bullish chart indicates low risk for the $1.63 billion company. The 1-year high was reported on Nov, 23 by Barchart.com. If the $68.29 price target is reached, the company will be worth $146.70 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 33,076 shares traded hands. Exponent, Inc. (NASDAQ:EXPO) has risen 24.63% since April 21, 2016 and is uptrending. It has outperformed by 19.30% the S&P500.
Analysts await Exponent, Inc. (NASDAQ:EXPO) to report earnings on February, 1. They expect $0.34 EPS, down 5.56% or $0.02 from last year’s $0.36 per share. EXPO’s profit will be $8.85 million for 46.07 P/E if the $0.34 EPS becomes a reality. After $0.42 actual EPS reported by Exponent, Inc. for the previous quarter, Wall Street now forecasts -19.05% negative EPS growth.
According to Zacks Investment Research, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.”
Insitutional Activity: The institutional sentiment decreased to 1.06 in 2016 Q2. Its down 0.65, from 1.71 in 2016Q1. The ratio dropped, as 12 funds sold all Exponent, Inc. shares owned while 39 reduced positions. 19 funds bought stakes while 68 increased positions. They now own 23.37 million shares or 1.97% more from 22.92 million shares in 2016Q1.
Nationwide Fund Advsr, a Pennsylvania-based fund reported 136,683 shares. State Street accumulated 0% or 506,941 shares. Ironbridge Mngmt Limited Partnership has 102,700 shares for 0.26% of their US portfolio. Royal Savings Bank Of Canada holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 17,833 shares. Archford Cap Strategies Lc last reported 0% of its portfolio in the stock. Fdx has 16,578 shares for 0.04% of their US portfolio. Gemmer Asset Mngmt Ltd holds 0% or 92 shares in its portfolio. Moreover, Ubs Asset Management Americas Inc has 0% invested in Exponent, Inc. (NASDAQ:EXPO) for 51,757 shares. Suntrust Banks Incorporated reported 7,360 shares or 0% of all its holdings. Morgan Stanley, a New York-based fund reported 7,753 shares. Thomson Horstmann And Bryant, a Connecticut-based fund reported 6,700 shares. Regions Fin reported 31,736 shares or 0.02% of all its holdings. California State Teachers Retirement System holds 0.01% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 53,642 shares. Ls Inv Ltd Liability Corp has invested 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO). Panagora Asset last reported 0.04% of its portfolio in the stock.
Insider Transactions: Since May 24, 2016, the stock had 0 insider purchases, and 14 selling transactions for $3.97 million net activity. The insider JOHNSTON PAUL R sold 5,500 shares worth $303,593. Boehm Paul sold $257,113 worth of Exponent, Inc. (NASDAQ:EXPO) on Monday, July 25. GAULKE MICHAEL R sold $238,198 worth of stock. $67,172 worth of Exponent, Inc. (NASDAQ:EXPO) was sold by CALIGIURI ROBERT D on Friday, August 12. Corrigan Catherine sold $219,504 worth of stock or 4,276 shares. Shares for $135,882 were sold by RIGGINS STEPHEN C on Tuesday, October 25. The insider Murray Steven J sold $19,501.
EXPO Company Profile
Exponent, Inc. (Exponent), incorporated on May 9, 1989, along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. The Company’s service offerings are provided on a project-by-project basis. It operates over 20 practices and centers in two operating divisions: Engineering and Other Scientific, and Environmental and Health. The Company’s Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, technology development, thermal sciences and vehicle analysis services. The Company’s Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences; epidemiology, biostatistics and computational biology; occupational and environmental health risk assessment, and toxicology and mechanistic biology. Exponent serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing and technology, among others.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.